NORTHERN TRUST CORP - BENITEC BIOPHARMA INC ownership

BENITEC BIOPHARMA INC's ticker is BNTC and the CUSIP is 08205P100. A total of 26 filers reported holding BENITEC BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of BENITEC BIOPHARMA INC
ValueSharesWeighting
Q2 2023$2,817
+13.6%
11,8130.0%0.00%
Q1 2023$2,480
+23.5%
11,8130.0%0.00%
Q4 2022$2,008
-49.8%
11,8130.0%0.00%
Q3 2022$4,000
-71.4%
11,8130.0%0.00%
Q2 2022$14,000
-50.0%
11,8130.0%0.00%
Q1 2022$28,000
-9.7%
11,8130.0%0.00%
Q4 2021$31,000
-26.2%
11,8130.0%0.00%
Q3 2021$42,000
-16.0%
11,8130.0%0.00%
Q2 2021$50,00011,8130.00%
Other shareholders
BENITEC BIOPHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 498,009$1,778,0001.00%
SUVRETTA CAPITAL MANAGEMENT, LLC 769,000$2,745,0000.05%
WealthTrust Axiom LLC 12,950$46,0000.02%
Private Wealth Advisors, LLC 15,043$49,0000.01%
Virtu Financial LLC 22,924$82,0000.01%
UBS Group AG 1,061$4,0000.00%
BANK OF AMERICA CORP /DE/ 91$00.00%
WELLS FARGO & COMPANY/MN 41$00.00%
NORTHERN TRUST CORP 11,813$42,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BENITEC BIOPHARMA INC shareholders